Cardinal Health Inc. (CAH)
CAH Stock May Gain Following the Distribution Deal With T2 Biosystems
Cardinal Health and T2 Biosystems announce an agreement selecting the former to sell direct-from-blood diagnostics for the rapid detection of sepsis-causing pathogens.
Reasons to Retain Cardinal Health Stock in Your Portfolio Now
CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is Cardinal Health (CAH) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cardinal Health to acquire Integrated Oncology Network for $1.12 billion
Cardinal Health on Friday agreed to acquire Integrated Oncology Network, an independent community oncology network, for $1.12 billion in cash.
Cardinal Health (CAH) Stock Falls Amid Market Uptick: What Investors Need to Know
Cardinal Health (CAH) reachead $110.76 at the closing of the latest trading day, reflecting a -0.58% change compared to its last close.
CAH Stock May Gain Following the Distribution Agreement With Telix
Cardinal Health and Telix announce an agreement selecting the former as a commercial radiopharmaceutical distributor to supply finished unit doses of Telix's Zircaix.
Why Cardinal Health (CAH) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Cardinal Health (CAH) Gained But Lagged the Market Today
In the latest trading session, Cardinal Health (CAH) closed at $113.28, marking a +0.1% move from the previous day.
Not All Dividend Aristocrats Are Created Alike. Here Are the 3 You Should Buy
Dividend investing has proved to be a reliable source of income for investors while allowing for long-term generational wealth accumulation.
Cardinal Health, Inc. (CAH) Baird's 2024 Global Healthcare Conference (Transcript)
Cardinal Health, Inc. (NYSE:CAH ) Baird's 2024 Global Healthcare Conference September 10, 2024 9:05 AM ET Company Participants Matt Sims - VP, IR Jason Hollar - CEO Aaron Alt - CFO Conference Call Participants Eric Coldwell - Baird Eric Coldwell Good morning, everyone. My name is Eric Coldwell.
Cardinal Health (CAH) Advances But Underperforms Market: Key Facts
The latest trading day saw Cardinal Health (CAH) settling at $112.80, representing a +0.92% change from its previous close.
